BCIQ Profiles

Company Profile Report
0913 Booster story
BioCentury & Getty Images

Politics, Policy & Law

Disputes at FDA over COVID boosters put spotlight on Friday panel

Advisory committee meeting could give airing to FDA’s internal disagreements about booster shots

Sep 14, 2021 | 12:08 AM GMT

Intra-agency disputes over pandemic policy played out in public Monday as FDA’s top vaccine regulators, Marion Gruber and Phil Krause, advocated against authorizing booster doses for most Americans at this time, while the Director of the Center for Biologics Evaluation and Research, Peter Marks, argued that third shots may be essential for protecting public health. The dispute sets up the Sept. 17 meeting of FDA’s Vaccines and Related Biological Products Advisory Committee as an opportunity to adjudicate the controversy.

News that Gruber and Krause, director and deputy director, respectively, of the Office of Vaccines Research & Review

Read the full 1334 word article

How to gain access

Continue reading with a
two-week free trial.